| answer text |
<p>DFID has a portfolio of investment and action across all five pillars of the World
Health Organisation’s Global Plan for Artemisinin Resistance Containment, through
our bilateral, multilateral and research support in Africa and Asia. This includes
support to programmes that aim to replace artemisinin monotherapy with artemisinin
combination therapy in the private sector in Burma; the Tracking Resistance to Artemisinin
Collaboration (TRAC) research programme; financial support to an Asian Development
Bank programme in South-East Asia, which aims to strengthen regional political leadership
and ownership of the issue; and to the Global Fund to Fight AIDS, TB and Malaria’s
regional Artemisinin Resistance Initiative.</p><p> </p><p> </p><p> </p><p>DFID is
also working with the World Health Organisation and other donors to develop strategies
to investigate the most effective ways to identify resistance and contain the spread.</p><p>
</p>
|
 |
